Loading resource…

Brigham and Women’s Hospital, Harvard Medical School
The article provides an in-depth analysis of the mechanisms by which SGLT2 inhibitors improve cardiovascular outcomes. It explores their effects on renal function, body weight, and various cardiovascular risk factors. The review also highlights clinical implications and potential adverse effects associated with these medications, emphasizing their importance in contemporary cardiovascular care.
No account needed